Bridging bench to body: ex vivo models to understand articular cartilage repair

Curr Opin Biotechnol. 2024 Jan 31;86:103065. doi: 10.1016/j.copbio.2024.103065. Online ahead of print.ABSTRACTWith little to no ability to self-regenerate, human cartilage defects of the knee remain a major clinical challenge. Tissue engineering strategies include delivering specific types of cells and biomaterials to the injured cartilage for restoration of architecture and function. Pre-clinical models to test the efficacy of the therapies come with high costs and ethical issues, and imperfect prediction of performance in humans. Ex vivo models represent an alternative avenue to trial cartilage tissue engineering. Defined as viable explanted cartilage samples, ex vivo models can be cultured with a cell-laden biomaterial or tissue-engineered construct to evaluate cartilage repair. Though human and animal ex vivo models are currently used in the field, there is a need for alternative methods to assess the strength of integration, to increase throughput and manage variability and to optimise and standardise culture conditions, enhancing the utility of these models overall.PMID:38301593 | DOI:10.1016/j.copbio.2024.103065
Source: Current Opinion in Biotechnology - Category: Biotechnology Authors: Source Type: research